Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,049 | 65,126 | 85,820 | 36,088 | 54,539 |
| Marketable Securities | 137,567 | 29,690 | N/A | 113,895 | 138,704 |
| Receivables | 9,387 | 1,785 | N/A | N/A | N/A |
| TOTAL | $268,777 | $100,189 | $92,665 | $155,078 | $198,369 |
| Non-Current Assets | |||||
| PPE Net | 13,897 | 19,495 | 26,294 | 32,931 | 36,125 |
| Investments And Advances | 51,225 | 1,400 | 1,400 | 1,400 | 36,752 |
| Other Non-Current Assets | 9,041 | 11,356 | 113 | 113 | 1,400 |
| TOTAL | $74,163 | $32,251 | $27,807 | $34,444 | $74,277 |
| Total Assets | $342,940 | $132,440 | $120,472 | $189,522 | $272,646 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,018 | 4,859 | 6,415 | 7,033 | 7,587 |
| Accrued Expenses | 14,226 | 10,884 | 15,207 | 12,513 | 10,812 |
| TOTAL | $46,415 | $45,993 | $42,041 | $31,625 | $30,457 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,639 | 24,648 | N/A | 8,989 | 10,730 |
| Deferred Revenues | 22,602 | 25,794 | 20,419 | 12,079 | 12,058 |
| Other Non-Current Liabilities | 11,564 | 16,178 | 644 | 1,129 | 0 |
| TOTAL | $121,775 | $134,771 | $126,476 | $97,198 | $109,558 |
| Total Liabilities | $168,190 | $180,764 | $168,517 | $128,823 | $140,015 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,577 | 3,554 | 2,052 | 2,032 | 2,018 |
| Common Shares | 91 | 70 | 41 | 40 | 40 |
| Retained earnings | -548,776 | -459,649 | -389,370 | -263,571 | -174,191 |
| Other shareholders' equity | -47 | 0 | 0 | -146 | -149 |
| TOTAL | $174,750 | $-48,324 | $-48,045 | $60,699 | $132,631 |
| Total Liabilities And Equity | $342,940 | $132,440 | $120,472 | $189,522 | $272,646 |